Becton Dickinson & Co. | Cash Flow

Fiscal year is October-September. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,293
1,185
695
976
1,100
311
Depreciation, Depletion & Amortization
546
562
891
1,114
1,088
1,978
Other Funds
23
27
47
85
235
81
Funds from Operations
1,559
1,861
1,455
2,160
2,921
1,968
Changes in Working Capital
158
115
275
399
371
897
Net Operating Cash Flow
1,717
1,746
1,730
2,559
2,550
2,865
Capital Expenditures
588
653
633
718
727
Sale of Fixed Assets & Businesses
736
-
-
158
165
Purchase/Sale of Investments
225
171
840
1
13
Net Investing Cash Flow
523
948
8,318
669
883
Cash Dividends Paid - Total
386
421
485
562
677
Issuance/Reduction of Debt, Net
199
4
6,655
1,252
7,282
Net Financing Cash Flow
968
807
6,190
1,761
10,977
Net Change in Cash
219
29
437
117
12,638
Free Cash Flow
1,195
1,154
1,134
1,866
1,823
Deferred Taxes & Investment Tax Credit
36
32
336
426
236
240
Net Assets from Acquisitions
136
40
8,414
-
174
Other Sources
211
-
-
-
-
Change in Capital Stock
406
409
27
32
4,607
Exchange Rate Effect
7
20
39
12
6
Other Uses
99
84
111
108
160

About Becton Dickinson &

View Profile
Address
1 Becton Drive
Franklin Lakes New Jersey 07417
United States
Employees -
Website http://www.bd.com
Updated 07/08/2019
Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences.